Cysal is an innovative biotechnology company based in Germany working in close partnership with the University of Münster and the Institute of Molecular Microbiology and Biotechnology. Our key interest is harnessing microbial metabolic diversity for the development of novel industrial fermentation technologies and products.

Cysal was founded in 2012 by an international and experienced team of scientific entrepreneurs with investment from eCapital entrepreneurial partners AG and High-Tech Gründerfonds GmbH. We offer services ranging from the development of fermentation-based technologies to the optimization and selection of microbial strains for the production of new compounds or activities. Our strength is our expertise in microbial physiology, fermentation technology, industrial biotechnology, and our dedicated research team.

We are also currently developing an own range of products based on our patented process for the industrial-scale biotechnological production of dipeptides.

Cysal is supported by an established and well-connected network of international collaborators and distribution partners in industry and academia.